Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature.
Children (Basel)
; 9(7)2022 Jul 01.
Article
in English
| MEDLINE | ID: covidwho-1917316
ABSTRACT
At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Topics:
Vaccines
Language:
English
Year:
2022
Document Type:
Article
Affiliation country:
Children9070993
Similar
MEDLINE
...
LILACS
LIS